Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
LLY · against 454 other Healthcare companies listed in US-listed
Ranked #69 of 455 · scores higher than 83% of peers
Bars: peers in each 10-point band of the growth score83 peers with a growth score of 90–100, including LLY · Click a bar to see the companies
Mainly thanks to its 3-year revenue growth, revenue growth and earnings per share growth, which are stronger than most Healthcare peers.
| Metric | LLY | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 475 reported | 49.6% | 10.8% | 82% | 33% | |
| Earnings per share growthHigher is better · 170 reported | 94.6% | 22.3% | 79% | 33% | |
| 3-year revenue growthHigher is better · 433 reported | 39.2% | 11.0% | 82% | 33% |
| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 551M USD | 100 | 53 | |
| 1 | 658M USD | 100 | 91 | |
| 3 | 1.4B USD | 99 | 73 | |
| 3 | 567M USD | 99 | 81 | |
| 3 | 10.3B USD | 99 | 33 | |
| 62 | 10.2B USD | 92 | 64 | |
| 62 | 2.8B USD | 92 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score
| 66 |
| 69 | 1.8B USD | 91 | 52 |
| 69 | 1.5B USD | 91 | 93 |
| 69 | 1.06T USD | 91 | 63 |
| 69 | 6.1B USD | 91 | 32 |
| 69 | 484M USD | 91 | 40 |
| 69 | 322M USD | 91 | 66 |
| 69 | 3.8B USD | 91 | 46 |